Cargando…
Pharmacotherapy for uveitis: current management and emerging therapy
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of sight loss in the working population. Most uveitis seen in Western countries is noninfectious and appears to be autoimmune or autoinflammatory in nature, requiring treatment with immunosuppressive and/or an...
Autores principales: | Barry, Robert J, Nguyen, Quan Dong, Lee, Richard W, Murray, Philip I, Denniston, Alastair K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181632/ https://www.ncbi.nlm.nih.gov/pubmed/25284976 http://dx.doi.org/10.2147/OPTH.S47778 |
Ejemplares similares
-
mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
por: Blair, Joshua, et al.
Publicado: (2018) -
An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review
por: McNally, Thomas W., et al.
Publicado: (2017) -
Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors
por: Okafor, Linda O., et al.
Publicado: (2017) -
Topical Anti-Inflammatory Agents for Non-Infectious Uveitis: Current Treatment and Perspectives
por: Balasubramaniam, Balini, et al.
Publicado: (2022) -
New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)